PORTLAND, Maine (AP) — A Maine pharmacy professor is receiving a grant of $375,000 for an early detection innovation in the breast cancer research field.
University of New England College of Pharmacy assistant professor Srinidi Mohan is receiving the grant from the Maine Cancer Foundation.
Mohan received a patent for an early detection, disease monitoring method that uses a marker in the blood to detect the presence of aggressive tumors. The university says Mohan’s innovation can also help track cancer growth.
The university says Mohan discovered the marker while studying nutritional supplements.
Most Read Stories
- With work permits in limbo, spouses of H-1B visa holders worry they’ll lose jobs
- King County Republican chair criticized after telling gun-control advocate 'Do not ever contact me again'
- Crashes involving 25 vehicles shut down snow-slicked I-90
- Man who accused Ed Murray of sexual abuse found dead in Auburn motel WATCH
- A Hall of Fame hitmaker finds happiness and harmony in Bellingham | PNW Magazine VIEW
Mohan will collaborate with Maine Medical Center Research Institute and a Maine-based company, Maine Biotechnology Services. The grant is a two-year award that will focus on developing a less-invasive indicator for certain kinds of breast tumor prognosis.